Bank of Montreal’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $125M | Sell |
789,273
-45,357
| -5% | -$6.13M | 0.04% | 338 |
|
|
2026
Q1 | $107M | Buy |
834,630
+672,007
| +413% | +$83.9M | 0.04% | 353 |
|
|
2025
Q4 | $19.8M | Buy |
162,623
+48,193
| +42% | +$5.53M | 0.01% | 858 |
|
|
2025
Q3 | $11.5M | Sell |
114,430
-26,128
| -19% | -$2.35M | ﹤0.01% | 995 |
|
|
2025
Q2 | $11.7M | Sell |
140,558
-14,867
| -10% | -$1.19M | 0.01% | 913 |
|
|
2025
Q1 | $12.6M | Sell |
155,425
-93,164
| -37% | -$8.33M | 0.01% | 856 |
|
|
2024
Q4 | $22.4M | Buy |
248,589
+4,793
| +2% | +$464K | 0.01% | 695 |
|
|
2024
Q3 | $24M | Buy |
243,796
+12,364
| +5% | +$1.21M | 0.01% | 711 |
|
|
2024
Q2 | $21.6M | Buy |
231,432
+17,749
| +8% | +$1.59M | 0.01% | 740 |
|
|
2024
Q1 | $21.5M | Sell |
213,683
-240,048
| -53% | -$22.3M | 0.01% | 716 |
|
|
2023
Q4 | $41.2M | Buy |
453,731
+197,954
| +77% | +$14.7M | 0.01% | 543 |
|
|
2023
Q3 | $19.9M | Buy |
255,777
+76,683
| +43% | +$6.13M | 0.01% | 717 |
|
|
2023
Q2 | $15.7M | Buy |
179,094
+159,915
| +834% | +$13.4M | 0.01% | 823 |
|
|
2023
Q1 | $1.67M | Sell |
19,179
-79,100
| -80% | -$6.56M | ﹤0.01% | 1772 |
|
|
2022
Q4 | $8.17M | Sell |
98,279
-307,523
| -76% | -$24.9M | ﹤0.01% | 1072 |
|
|
2022
Q3 | $34.9K | Buy |
405,802
+279,006
| +220% | +$23.5M | 0.02% | 485 |
|
|
2022
Q2 | $9.54K | Buy |
126,796
+14,673
| +13% | +$1.1M | ﹤0.01% | 1089 |
|
|
2022
Q1 | $10.5M | Buy |
112,123
+59,266
| +112% | +$5.47M | 0.01% | 1124 |
|
|
2021
Q4 | $6.03M | Sell |
52,857
-32,895
| -38% | -$3.97M | ﹤0.01% | 1157 |
|
|
2021
Q3 | $11.1M | Buy |
85,752
+51,570
| +151% | +$6.64M | 0.01% | 1225 |
|
|
2021
Q2 | $4.72M | Buy |
34,182
+20
| +0.1% | +$2.63K | ﹤0.01% | 1638 |
|
|
2021
Q1 | $4.53M | Sell |
34,162
-10,223
| -23% | -$1.53M | ﹤0.01% | 1402 |
|
|
2020
Q4 | $6.57M | Sell |
44,385
-13,663
| -24% | -$1.75M | ﹤0.01% | 1242 |
|
|
2020
Q3 | $6.67M | Sell |
58,048
-149,821
| -72% | -$16.8M | 0.01% | 1048 |
|
|
2020
Q2 | $24.1M | Buy |
207,869
+196,117
| +1,669% | +$19.3M | 0.02% | 526 |
|
|
2020
Q1 | $892K | Sell |
11,752
-309
| -3% | -$27.4K | ﹤0.01% | 1746 |
|
|
2019
Q4 | $1.15M | Sell |
12,061
-6,760
| -36% | -$585K | ﹤0.01% | 2184 |
|
|
2019
Q3 | $1.44M | Sell |
18,821
-2,818
| -13% | -$234K | ﹤0.01% | 1890 |
|
|
2019
Q2 | $1.9M | Sell |
21,639
-4,269
| -16% | -$364K | ﹤0.01% | 1723 |
|
|
2019
Q1 | $2.35M | Sell |
25,908
-155,004
| -86% | -$13.2M | ﹤0.01% | 1579 |
|
|
2018
Q4 | $13M | Sell |
180,912
-48,676
| -21% | -$3.92M | 0.01% | 696 |
|
|
2018
Q3 | $22M | Buy |
229,588
+37,396
| +19% | +$3.63M | 0.02% | 616 |
|
|
2018
Q2 | $18.3M | Sell |
192,192
-11,692
| -6% | -$1.07M | 0.02% | 656 |
|
|
2018
Q1 | $17.9M | Buy |
203,884
+2,654
| +1% | +$242K | 0.02% | 639 |
|
|
2017
Q4 | $17.1M | Buy |
201,230
+14,694
| +8% | +$1.23M | 0.01% | 672 |
|
|
2017
Q3 | $16.1M | Sell |
186,536
-28,399
| -13% | -$2.28M | 0.01% | 664 |
|
|
2017
Q2 | $16.6M | Sell |
214,935
-122,193
| -36% | -$8.67M | 0.02% | 645 |
|
|
2017
Q1 | $23.4M | Buy |
337,128
+255,846
| +315% | +$17.2M | 0.02% | 513 |
|
|
2016
Q4 | $5.09M | Buy |
81,282
+75,137
| +1,223% | +$4.64M | 0.01% | 1078 |
|
|
2016
Q3 | $407K | Buy |
6,145
+3,577
| +139% | +$221K | ﹤0.01% | 2166 |
|
|
2016
Q2 | $139K | Sell |
2,568
-714
| -22% | -$39.1K | ﹤0.01% | 2656 |
|
|
2016
Q1 | $170K | Buy |
3,282
+1,956
| +148% | +$102K | ﹤0.01% | 2554 |
|
|
2015
Q4 | $93K | Sell |
1,326
-327
| -20% | -$22.3K | ﹤0.01% | 2801 |
|
|
2015
Q3 | $103K | Buy |
1,653
+273
| +20% | +$21.5K | ﹤0.01% | 2613 |
|
|
2015
Q2 | $115K | Buy |
1,380
+261
| +23% | +$20.3K | ﹤0.01% | 2678 |
|
|
2015
Q1 | $84K | Buy |
1,119
+585
| +110% | +$40.9K | ﹤0.01% | 2703 |
|
|
2014
Q4 | $34K | Buy |
534
+234
| +78% | +$13.3K | ﹤0.01% | 3179 |
|
|
2014
Q3 | $16K | Hold |
300
| – | – | ﹤0.01% | 3537 |
|
|
2014
Q2 | $15K | Buy |
+300
| New | +$13.5K | ﹤0.01% | 3719 |
|
Other funds holding XBI
Bank of Montreal's XBI Position: Q2 2026 in Review
Bank of Montreal reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.4% in Q2 2026, selling an estimated $6.13M and leaving 789,273 shares worth $125M. The position accounts for 0.04% of the portfolio, ranked #338.
Bank of Montreal first reported a position in XBI in Q2 2014 and has held it in 49 quarters since. 837 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Bank of Montreal held 789,273 shares of State Street SPDR S&P Biotech ETF worth $125M as of Q2 2026.
- Bank of Montreal sold 45,357 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $6.13M.
- State Street SPDR S&P Biotech ETF made up 0.04% of Bank of Montreal's portfolio in Q2 2026, its #338 holding.
- Bank of Montreal first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 49 quarters since.
- 837 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.